Interstitial lung abnormalities in smokers are associated with increased mortality

N. Hoyer (København S, Denmark)

Source: International Congress 2017 – ILDs: clinical problems
Session: ILDs: clinical problems
Session type: Thematic Poster
Number: 862
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Hoyer (København S, Denmark). Interstitial lung abnormalities in smokers are associated with increased mortality. 862

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The associations of interstitial lung abnormalities with cancer diagnoses and mortality
Source: Eur Respir J, 56 (6) 1902154; 10.1183/13993003.02154-2019
Year: 2020



Interstitial lung diseases, mortality and associated risk factors
Source: Eur Respir J 2004; 24: Suppl. 48, 667s
Year: 2004

Lymphopenia is linked to an increased incidence of cancer in smokers without COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Diaphragm dysfunction in combination with lung function decline is associated with higher mortality in idiopathic pulmonary fibrosis patients
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

Weight loss as a predictor of mortality in patients with interstitial lung disease
Source: Eur Respir J, 52 (3) 1801289; 10.1183/13993003.01289-2018
Year: 2018



Risk factors associated with the development of interstitial lung abnormalities
Source: Eur Respir J, 58 (2) 2003005; 10.1183/13993003.03005-2020
Year: 2021



Associations between comorbidities and survival in patients with interstitial lung diseases
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015



Treatment and prognosis of lung cancer associated with interstitial pneumonia
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010


Overall survival is significantly higher in sarcoidosis than in IPF patients after lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Smoking and interstitial lung diseases
Source: Eur Respir Rev 2015; 24: 428-435
Year: 2015



COPD and lung cancer incidence in never smokers
Source: International Congress 2019 – Asthma and COPD comorbidities
Year: 2019



High short-term mortality following lung biopsy for usual interstitial pneumonia
Source: Eur Respir J 2001; 17: 175-179
Year: 2001



Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018

Biomarkers in pulmonary hypertension associated to interstitial lung disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010

Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Increased relative mortality in women with severe oxygen-dependent COPD
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


Markers of systemic inflammation are associated with increased symptoms and respiratory exacerbations among smokers with preserved spirometry in SPIROMICS
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018



Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016



Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality
Source: Eur Respir J 2010; 35: 1303-1311
Year: 2010